AiViva BioPharma
AiViva BioPharma
  • Home
    • Overview
    • Management Team
    • Board of Directors
    • Partner With Us
    • Join Our Team
    • Scientific Overview
    • Therapeutic Areas
    • Development Pipeline
    • AIV001
    • AIV007
    • JEL™ Technology
    • Recent News
    • Upcoming Events
    • Science in the News
    • Home
    • Company
      • Overview
      • Management Team
      • Board of Directors
      • Partner With Us
      • Join Our Team
    • Areas of Focus
      • Scientific Overview
      • Therapeutic Areas
    • Pipeline
      • Development Pipeline
      • AIV001
      • AIV007
      • JEL™ Technology
    • News
      • Recent News
      • Upcoming Events
      • Science in the News
  • Home

Innovative Products, transformational treatments

Innovative Products, transformational treatmentsInnovative Products, transformational treatmentsInnovative Products, transformational treatments

We work to address the challenges of difficult-to-treat diseases that have clear unmet medical needs

Innovative Products, transformational treatments

Innovative Products, transformational treatmentsInnovative Products, transformational treatmentsInnovative Products, transformational treatments

We work to address the challenges of difficult-to-treat diseases that have clear unmet medical needs

AiViva BioPharma is a clinical-stage biotech company led by a team of seasoned industry experts with a proven track record in the development of commercial drug products.  AiViva has developed novel technologies to address unmet medical needs by transforming existing treatments to create localized, targeted treatment of diseases while lowering systemic exposure.  Our core competency includes development of drugs using our proprietary JEL™ Technology in specialty therapeutic areas of Dermatology, Ophthalmology, Urology, and Oncology.

Company Overview
image101

 We are looking forward to another year of progress and accomplishments at AiViva as we continue to work toward our mission of addressing unmet medical needs with our innovative solutions. The year of 2020 has been challenging for all.  As we reflect back, we have reason to celebrate this holiday season.  AiViva completed our first clinical trial in dermal scarring and wound healing with positive results and initiated a trial in nonmelanoma skin cancer.  We look forward with great optimism to a new year to bring us closer to helping patients.


We hope 2021 will bring success for all those working to advance medical treatments to improve patient care and quality of life. Let 2021 be a year of new discoveries, innovations, and improved medicines for patients. 


Wishing you all good health and a great year ahead!

About Us

image102

Development Strategy

AiViva targets specialty therapeutic areas where there is a clear unmet medical need, and where our innovative products would provide a solution to reduce the treatment burden for both patients and physicians  

Scientific Approach

Areas of Focus

image103

Dermatology

Ophthalmology

Ophthalmology

image104

Ophthalmology

Ophthalmology

Ophthalmology

image105

Urology

Oncology

Oncology

image106

Oncology

Oncology

Oncology

image107

JEL™ Technology

Our proprietary JEL™ Technology is customizable to achieve optimal duration of drug effect ranging from weeks to months allowing us to create novel formulations and explore new clinical uses for drugs

Learn more

Contact US

AiViva BioPharma

1300 Bristol St N, Suite 220, Newport Beach, California 92660, United States

(949) 662-1949



  • Home
  • Overview
  • Partner With Us
  • Therapeutic Areas
  • Development Pipeline
  • Recent News